Increased osteoclastic activity in acute Charcot's osteoarthopathy: The role of receptor activator of nuclear factor-kappaB ligand

Diabetologia

Volumn 51, Issue 6, 2008, Pages 1035-1040

  Mabilleau, G ^a   Petrova, N L ^b   Edmonds, M E ^b   Sabokbar, A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Charcot's osteoarthropathy; OPG; Osteoclasts; Osteolysis; RANKL; Resorption

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLONY STIMULATING FACTOR 1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ADULT; ARTICLE; CELL ACTIVITY; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DENTIN; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; NEUROPATHIC JOINT DISEASE; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ARTHROPATHY, NEUROGENIC; BONE RESORPTION; CELL CULTURE TECHNIQUES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MONOCYTES; NF-KAPPA B; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 43049127440     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-0992-1     Document Type: Article

References (22)

1. Gough A, Abraha H, Li F et al (1997) Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy. Diabet Med 14:527-531
2. Teitelbaum SL (2000) Bone resoption by osteoclasts. Science 289:1504-1508
3. Yasuda H, Shima N, Nakagawa N et al (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95:3597-3602
4. Hofbauer LC, Schoppet M (2004) Clinical implications of the osteoprotegerin/ RANKL /RANK system for bone and vascular diseases. JAMA 292:490-495
5. Jeffcoate W (2004) Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link? Diabetelogia 47:1488-1492
6. Sabokbar A, Athanasou NS (2003) Generating human osteoclasts from peripheral blood. Methods Mol Med 80:101-111
7. Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA (1996) The human osteoclast precursors circulate in the monocyte fraction. Endocrinology 137:4058-4060
8. Sanders LJ, Frykberg RG (2001) Charcot neuroarthropathy of the foot. In: Bowker JH, Phiefer MA (eds) Levin & O'Neal's the diabetic foot. 6th edn. Mosby, St Louis, pp 439-466
9. Flanagan AM, Lader CS (1998) Update on the biologic effects of monocyte-macrophage colony-stimulating factor. Curr Opin Hematol 5:181-185
10. Motoyoshi K (1998) Biological activities and clinical application of M-CSF. Int J Hematol 67:109-122
11. Kobayashi K, Takahashi N, Jimi E et al (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by mechanism independent of ODF/RANKL-RANK-interaction. J Exp Med 191:257-286
12. Kudo O, Fujikawa Y, Itonaga I, Sabokbar A, Torisu T, Athanasou NA (2002) Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation. J Pathol 198:220-227
13. Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, Athanasou NA (2003) Interleukin-6 and interleukin-11 support human osteoclast formation by RANKL-independent mechanism. Bone 32:1-7
14. Bendre MS, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ (2003) Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 33:28-37
15. Edwards JR, Sun SG, Locklin R et al (2006) LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis. Arthritis Rheum 54:1451-1462
16. Hirayama T, Danks L, Sabokbar A, Athanasou NA (2002) Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis. Rheumatology 41:1232-1239
17. Zou W, Bar-Shavit Z (2002) Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 17:1211-1218
18. Grimaud E, Soubigou L, Couillaud S et al (2003) Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol 163:2021-2031
19. Jeffcoate WJ, Game F, Cavanagh P (2005) The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet 366:2058-2061
20. Baumhauer JF, O'Keefe RJ, Schon LC, Pinzur MS (2006) Cytokine-induced osteoclastic bone resorption in Charcot arthropathy: an immunohistochemical study. Foot Ankle Int 27:797-800
21. Adamopoulos IE, Sabokbar A, Wordsworth BP, Carr A, Ferguson DJ, Athanasou NA (2006) Synovial fluid macrophages are capable of osteoclast formation and resorption. J Pathol 208:35-43
22. Sabokbar A, Kudo O, Athanasou NA (2003) Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. J Orthop Res 21:73-80